Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

AbbVie Inc.

ABBV•NYSE
Healthcare
Drug Manufacturers - General
$229.48
$4.67(2.08%)
U.S. Market opens in 15h 52m

AbbVie Inc. (ABBV) Stock Overview

Explore AbbVie Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap405.6B
P/E Ratio95.29
EPS (TTM)$2.36
ROE-4.22%
Fundamental Analysis

AI Price Forecasts

1 Month$255.15
3 Months$230.46
1 Year Target$236.43

ABBV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AbbVie Inc. (ABBV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 56.44, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $236.43.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 95.29 and a market capitalization of 405.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.09%
5-Day Change
-1.92%
1-Month Change
4.67%
3-Month Change
-2.87%
6-Month Change
8.97%
Year-to-Date (YTD) Change
0.08%
1-Year Change
12.46%
3-Year Change
50.92%
5-Year Change
115.96%
All-Time (Max) Change
555.71%

Contact Information

https://www.abbvie.com
847 932 7900
1 North Waukegan Road, North Chicago, IL, 60064-6400

Company Facts

550,000 Employees
IPO DateJan 2, 2013
CountryUS
Actively Trading

Frequently Asked Questions